News Highlights: Top Company News of the Day
April 16 2021 - 1:30PM
Dow Jones News
Morgan Stanley Books Archegos Loss, but Profit Hits New High
The bank lost $911 million when Archegos Capital Management
imploded last month, tarnishing a record-setting quarter.
Indianapolis FedEx Shooting Leaves at Least Eight Dead
The gunman arrived at the parking lot, got out of his car and
started shooting. After killing people outside and inside the
facility, he apparently killed himself.
Apple Music Reveals How Much It Pays When You Stream a Song
The company pays the music industry a penny per stream on its
service, a disclosure it made as part of an effort by
music-streaming services to show they are artist-friendly.
Hertz Bankruptcy Bidding War Heats Up With New Counteroffer
Knighthead Capital Management and Certares Management, which
previously offered to buy Hertz out of bankruptcy but were eclipsed
by a competing group, returned with a sweetened bid.
Simon & Schuster Won't Distribute Policeman's Book About Breonna Taylor Shooting
The book's author, Jonathan Mattingly, was one of the three
Louisville police officers who fired their weapons during last
year's raid.
ESG Insights - Johnson & Johnson Under the Microscope
This week, The Wall Street Journal's ESG research analysts
looked at J&J's vaccine pause, Microsoft's acquisition of
Nuance, the Veolia-Suez deal, Air Canada and more.
Toshiba Shareholders May Finally Get Their Due
Storied Japanese company Toshiba has a long history of
governance problems, but the prospect of a bidding war means things
could finally be looking up.
J&J Privately Asked Rival Vaccine Makers to Probe Clot Risks
AstraZeneca was interested in joining forces to investigate the
safety issue and communicate vaccine benefits and risks, but Pfizer
and Moderna didn't see the need for group action.
Mercedes-Benz Faces an Open Road Today, Traffic Tomorrow
Two exceptionally profitable quarters for the luxury-car brand
highlight what Daimler has to lose from the transition to electric
vehicles.
Lilly Seeks to End U.S. Use of Single Covid-19 Antibody Drug Alone
The drugmaker said it will distribute a drug cocktail containing
bamlanivimab and a second antibody, etesevimab, that studies
indicate together neutralize more of the emerging Covid-19
variants.
(END) Dow Jones Newswires
April 16, 2021 13:15 ET (17:15 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.